Cleared Traditional

K812253 - GELMAN IG-FIX KIT

K812253 is the FDA 510(k) clearance for GELMAN IG-FIX KIT by Gelman Sciences, Inc.. It is a Class 2 Chemistry device (product code CZP) cleared through the Traditional 510(k) pathway after a 21-day FDA review.

K812253 · Gelman Sciences, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1981
Decision
21d
Days
Class 2
Risk

K812253 is an FDA 510(k) clearance for the GELMAN IG-FIX KIT. Classified as Iga, Antigen, Antiserum, Control (product code CZP), Class II - Special Controls.

Submitted by Gelman Sciences, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 1, 1981 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 866.5510 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Gelman Sciences, Inc. devices

Submission Details

510(k) Number K812253 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 11, 1981
Decision Date September 01, 1981
Days to Decision 21 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 88d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CZP Iga, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CZP Iga, Antigen, Antiserum, Control

All 43
Devices cleared under the same product code (CZP) and FDA review panel - the closest regulatory comparables to K812253.
ACA IMMUNOGLOBIN A TEST PACK
K812631 · E.I. Dupont DE Nemours & Co., Inc. · Sep 1981
ACA IMMUNOGLOBULIN A/M CALIBRATORS
K812633 · E.I. Dupont DE Nemours & Co., Inc. · Sep 1981
IMMUNOGL. FRCT. OF RABBIT ANTISER.-IGA
K812488 · Dako Corp. · Sep 1981
AIM SYSTEM (FOR IGA)
K811125 · Icl Scientific · May 1981
AUTOMATED IMMUNOPRECIPITIN METHOD/IGA
K803274 · Icl Scientific · Jan 1981
J.T. BAKER IMMUNO. A NEPHELOMETRIC ASSAY
K801283 · J.T. Baker Chemical Co. · Jun 1980